Urologist at Saarland University Medical Center (Homburg/Saar)
Joined October 2017
- Tweets33
- Following142
- Followers106
- Likes134
Johannes Linxweiler retweeted
Announcing the Chopin Award for Non-Urologist Researchers. A new award to honour exceptional translational research shaping the future of urologic care.
Deadline to apply: 17 January 2026
To learn more about the awards application requirements visit: eaucongress.uroweb.org/the-c…
Johannes Linxweiler retweeted
📣 Angesichts wachsender Einschränkungen der Forschungsfreiheit in den USA startet die @EKFStiftung ein neues Förderprogramm mit 10 Mio. €:
Ziel ist es, exzellenten Medizinforschenden aus den USA langfristig eine Perspektive in Deutschland zu geben. ➡️ sohub.io/gcz8
Johannes Linxweiler retweeted
Dieses Jahr findet das 15. Symposium der Arbeitsgruppe urologische Forschung (AuF) in Homburg/Saar statt. Ich freue mich, zusammen mit @JLinxweiler, Christoph Becker und Miriam Albert die Organisation dieses Symposiums begleiten zu dürfen.
@DGUrologie
Johannes Linxweiler retweeted
❗️Abstract deadline extended to 14.10.2024❗️
👇👇👇
urologenportal.de/auf-sympos…
@DGUrologie
@GeSRU_de
@GesruAcademics
#urology
Johannes Linxweiler retweeted
Nectin-4—drug conjugates (in metastatic urothelial carcinomas): The right drug for everyone?
Happy to talk about current evidence to use Nectin-4 status to predict Enfortumab vedotin response in met. UC at #EAU24 in Paris @Uroweb !
Very interesting Session on saturday about „Tumour and patient biology for optimised treatment“ 🎯
@LDyrskjot @JLinxweiler @Markuseckstein3 @ViktorGruenwald @imedverse @drenriquegrande @DrYukselUrun @amerseburger @urotoday
Johannes Linxweiler retweeted
With a median FU up of ~5 yrs adjuvant pembro= 38% reduction in risk of death. The benefit is across subgroups (T stage etc). Subsequent therapy in 80% is relapses. The 1st +ve OS adjuvant PD1 study, making adjuvant pembro more attractive. #GU24 @DrChoueiri
Johannes Linxweiler retweeted
Really grateful to have the opportunity presenting our work at #GU24 !! Genomic protein related biomarkers might be good correlated for precise smart targeted chemotherapies! @ASCO @urotoday @OncoAlert @shilpaonc @drenriquegrande @PGrivasMDPhD @ViktorGruenwald
NECTIN4 amplification predicts response to Enfortumab vedotin in mUC! It occurs frequently across solid tumors (app. 25% of mUC)➡️potential tumor-agnostic biomarker for NECTIN4-targeting therapies! Happy to share our poster K17 @ASCO #GU24! @Markuseckstein3 @OncoAlert @urotoday
Johannes Linxweiler retweeted
Delighted for this highlighting by @EUplatinum @niklas_kluemper @AlexanderCoxMD @OncoAlert
More to come soon !!
Articles in Press: Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution
buff.ly/426HFWO
@niklas_kluemper @JohannesStein9 @ChrisBolenz @roghmann @HolzelMichael @Markuseckstein3
#UroSoMe #Medtwitter
Johannes Linxweiler retweeted
UROlogisch!
Folge 32: Moderne Therapie des Blasenkarzinoms (III): The Great Leap?
Tolle Neuigkeiten, kompakt und kompetent erklärt.
buff.ly/3O8BSKi
Johannes Linxweiler retweeted
Join us at the @biozentrum in Basel for the #ESUR23 meeting to discuss the latest discoveries in #urologicalresearch! We will cover topics such as patient-derived #organoid and #mouse models, combination #therapies, #infectiology , #spatialbiology and #extracellularvesicles – at Basel, Switzerland
⏰#ESUR23 registration savings end next week! Join us for three days of top-notch #UrologicalResearch 🔬 in Basel, Switzerland. This is your opportunity to collaborate with experts from around the globe.
Sign up here by 11 Oct (23:59 CEST)
👉 esur.uroweb.org/how-to-regis…
Johannes Linxweiler retweeted
Are you curious about what is planned for #ESUR23? This new interview with ESUR Chair Prof. Kerstin Junker provides insights into the scientific programme planned for this year's edition in Basel. See what ESUR23 has in store for you!
esur.uroweb.org/esur23-exper…
Johannes Linxweiler retweeted
Only 5️⃣ days to go! The #ESUR23 abstract submission deadline is this Sunday, 2 July (24:59 CEST).
⭐Have you conducted urology research with definitive results that you want to share with experts & your colleagues? #UrologicalResearch
Submit here 👇
esur.uroweb.org/scientific-p…
Johannes Linxweiler retweeted
📌Calling all urology scientists! Do you have quality research to share? Abstract submissions are now open for the 29th Meeting of the EAU Section of Urological Research (#ESUR23).
See the topic list & more details here 👇esur.uroweb.org/scientific-p…
#UrologicalResearch
Johannes Linxweiler retweeted
The #ESUR22 Abstract Submission deadline has been extended to 1 AUGUST! We know groundbreaking research and summer vacation don't mix. You have 2 weeks more to submit your research and join us in Innsbruck for a meeting of urological experts.
Submit now 👇
esur.uroweb.org/scientific-p…
Johannes Linxweiler retweeted
Identification of tumour specific markers on extracellular vesicles - successful isolation of EVs from different sources for development of specific markers. Another figure we recognise! Here's the paper by @JLinxweiler et al. rdcu.be/cQWxN
Johannes Linxweiler retweeted
Robotic Salvage Lymph Node Dissection in Recurrent Prostate Cancer: Lessons Learned from 68 Cases and Implications for Future Clinical Management
bit.ly/2RT3fyd @JLinxweiler
Johannes Linxweiler retweeted
SCIENCE:
If you don't make mistakes, you're doing it wrong.
If you don't correct those mistakes, you're doing it really wrong.
If you can't accept that you're mistaken, you're not doing it at all.
Johannes Linxweiler retweeted
Congratulations to @chariskalogirou and Wolfgang Fendler for receiving the Alken Award 2019. #prostatecancer #PSMA
Johannes Linxweiler retweeted
ESUR19 will be held on 10-12 October 2019 in Porto!
You are invited to be a part of this outstanding meeting.
esur.uroweb.org
#ESUR19
Johannes Linxweiler retweeted
Don't miss ESUR19: the yearly opportunity for researchers to meet and share results in all fields of urological research.
▶️ Registration is open. Benefit from Early Fee.
esur.uroweb.org/register/del…
▶️ Submit your abstract before 8 July 2019.
esur.uroweb.org/scientific-p…